Small antitrust lawsuit explodes into investigation of alleged price-fixing involving at least 16 companies and 300 drugs
Executives at more than a dozen generic-drug companies had a form of shorthand to describe how they conducted business, insider lingo worked out over steak dinners, cocktail receptions and rounds of golf. The “sandbox,” according to investigators, was the market …